Clinical trial
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
NCT00351234
Study timeline
Study start (unknown)2004-10-01Date precision: month
Registry last updated2012-02-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type Iunresolved
Hypoglycemiaunresolved
Interventions
Carnitine (drug)DRUG
Sponsors & collaborators
Children's Mercy Hospital Kansas Citylead sponsor
Leadiant Biosciences, Inc.collaborator
Minimed Pharmaceuticalscollaborator
Pharmacia/Upjohn Career Development Awardcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00351234 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.